Author Correction: The Type II RAF Inhibitor Tovorafenib in Relapsed/refractory Pediatric Low-grade Glioma: the Phase 2 FIREFLY-1 Trial
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Lim-Fat M, Bennett J, Ostrom Q, Touat M, Franceschi E, Schulte J Neuro Oncol. 2024; 27(1):13-32.
PMID: 39441704 PMC: 11726256. DOI: 10.1093/neuonc/noae186.